Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael

Showing results (991-1000 of 1,111) with videos related to

Pageof 112
Sort By:
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
HLA tapasin independence: broader peptide repertoire and HIV controlArman A Bashirova, Mathias Viard, Vivek Naranbhai, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Pageof 112

Showing results (991-1000 of 1,111) with videos related to

Sort By:
Pageof 112
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
HLA tapasin independence: broader peptide repertoire and HIV controlArman A Bashirova, Mathias Viard, Vivek Naranbhai, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Pageof 112